Given the multitude of new treatment options for psoriasis, including topicals, phototherapy, oral systemic therapy, and injectable biologics, the treatment of the disease has truly become an art.

This book passes on this art to practicing physicians in a very practical and easy-to-use format, focusing on mild, moderate, and severe psoriasis. Offering evidence-based information in a concise text, this book discusses new treatment options, including topicals, phototherapy, oral systemic therapy, and injectable biologics. This second edition updates all the chapters from the previous edition and offers unique methods of use, such as sequential and combination therapy. In addition, the book includes high quality color photographs and tables for quick and easy reference.

Evidence-Based Psoriasis, 2nd Edition, is written for practicing dermatologists, residents, and primary care physicians. 

Dr. Tina Bhutani is a board certified dermatologist and clinical researcher practicing in San Francisco, California where she is the CEO of Synergy Dermatology. She received her medical training at the University of Southern California Keck School of Medicine and completed her residency in dermatology at UCSF. Dr. Bhutani has an expertise in the treatment of psoriasis, atopic dermatitis, and other inflammatory skin diseases. In addition to seeing patients, she is an Associate Clinical Professor in the Department of Dermatology at UCSF and the former Director of the Clinical Trials Unit for the department. She is passionate about improving the care and lives of patients with inflammatory skin disorders and is involved in many studies focusing on the development of new treatments for these diseases and learning more about mechanisms of disease initiation and maintenance. She has a particular interest in the impact of disease on patient quality of life and mental health as well as the use of wellness-based behavior modification to improve disease severity and reduce the risk of associated comorbidities.  She has published over 150 articles in peer-reviewed journals and has spoken at national and international conferences on these topics. She is a member of the National Psoriasis Foundation (NPF) Scientific Advisory committee and Medical Advisory Board. She has also received research grant funding from the NPF, the Dermatology Foundation, as well as Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). She serves as the current editor-in-chief for the journal Psoriasis: Targets and Therapy. 

Dr. Wilson Liao is Professor of Dermatology and Director of the Psoriasis and Skin Treatment Center at the University of California San Francisco. He is a practicing dermatologist with expertise in biologic therapy and phototherapy. Dr. Liao holds leadership positions with the National Psoriasis Foundation, International Psoriasis Council, and Group for Research and Assessment of Psoriaisis and Psoriatic Arthritis. Dr. Liao is a co-founder of Trex Bio, a biotechnology company developing novel therapeutics for inflammatory skin disease, and Solay Health, a telehealth company offering in-home therapy for psoriasis and eczema. Dr. Liao is also engaged in digital health initiatives and has developed SkinTracker, a mobile app allowing for the conduct of remote dermatology trials.

Dr. Mio Nakamura is a board-certified dermatologist and an Associate Professor of Dermatology at the University of Michigan. Dr. Nakamura is a medical dermatologist who sub-specializes in inflammatory and autoimmune skin disease. Dr. Nakamura maintains a strong interest in clinical research and serves as the Director of the Program for Clinical Research in Dermatology (PCRiD) and the Associate Medical Director of the Michigan Clinical Trials Unit (M-CTSU) and Clinical Research Unit (MCRU).